Feb. 6 at 9:08 AM
$SANA I have 2 questions for
$SANA experts:
1- why this -12.8% down yesterday ? I do not see any particular news here.
2- can someone help me understand the relatively high market cap for
$SANA (around
$1 Billion) ? As someone said below, it's a very early stage biopharma, with no products on the market or near to be in a foreseable future.
In comparison, it's approximatively the same marketcap as
$MLTX 's, which drug is in a far more advanced stage (and recently got FDA's Fast Track status)
$BMEA as well is an early stage pharma, while valued only
$80 Million, 12x less than SANA...Yet, Biomea's drugs' early datas are stunning.
Thanks in advance. Please try answering in an non-agressive way. Just want to discsuss gently on the points above.
